ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아다젠 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 7%의 성장률로 1억 2,360만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 약물 전달 시스템의 지속적인 혁신, 신흥국의 의료 인프라 성장, 효소 보충 요법에 대한 접근성 증가, 지원적인 상환 정책, 유전성 질환의 유병률 증가에 기인하는 것으로 추정됩니다. 예측 기간 동안 주요 동향으로는 바이오시밀러 효소대체요법 도입, 제조 비용 절감, 헬스케어 공급망 디지털화, 바이오테크 기업과 학계의 협력, 장기지속형 제제의 발전 등을 꼽을 수 있습니다.
정밀의료의 채택 확대는 아다젠 시장의 성장을 크게 견인할 것으로 예측됩니다. 유전체 기술의 발전, 바이오마커의 가용성, 인공지능의 통합, 표적치료에 대한 수요 증가로 인해 개인별 유전자 프로파일에 맞추어 치료법을 조정하는 정밀의료가 각광받고 있습니다. 아다젠은 아데노신 분해효소 결핍으로 인한 중증 복합 면역결핍증(SCID) 환자에게 표적 효소 대체요법을 제공함으로써 이러한 변화에 직접적으로 부합하고 있으며, 2023년 FDA는 희귀질환에 대한 16개의 새로운 맞춤형 치료제를 승인하여 정밀의료의 채택이 확대되고 있음을 반영하고 있습니다. 아다젠 시장을 지속적으로 견인할 것으로 예측됩니다.
2,000명 중 1명 이하가 앓고 있는 희귀질환의 진단 건수 증가가 아다젠 시장의 성장을 가속하고 있으며, 유전자 검사의 발전, 인식 개선, 의료 인프라의 개선으로 진단 빈도가 증가하고 있습니다. 아다젠은 효소대체요법을 제공함으로써 희귀 유전질환인 SCID의 치료에 기여하고, 조기 진단과 희귀질환에 대한 광범위한 조사를 지원하고 있습니다. 영국에서만 350만 명 이상의 사람들이 희귀질환을 앓고 있으며, 아다젠과 같은 치료제의 필요성을 강조하며 시장 수요를 더욱 높이고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장 제품 특성
분자 유형
투여 경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스, 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 아다젠 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 아다젠 시장 : 성장률 분석
세계의 아다젠 시장 실적 : 규모와 성장, 2019-2024년
세계의 아다젠 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 아다젠 : 전체 잠재 시장 규모(TAM)
제7장 세계 시장 가격 분석과 예측
제8장 시장 세분화
세계의 아다젠 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
프리필드
바이알
세계의 아다젠 시장 : 질환별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
중증 복합 면역 결핍증(SCID)
기타 희소 유전성 질환
세계의 아다젠 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 및 의료기관
전문 클리닉
재택 헬스케어 서비스
연구기관
제9장 임상 적응증 세계 시장 역학
약제 부작용
임상 적응증 발증률과 유병률
제10장 지역별/국가별 분석
세계의 아다젠 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 아다젠 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 개요
아다젠 시장 : 경쟁 구도
아다젠 시장 : 기업 개요
Leadiant Biosciences Inc.
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장 잠재력이 높은 국가, 전략
아다젠 시장, 2029년 : 새로운 기회를 제공하는 국가
아다젠 시장, 2029년 : 새로운 기회를 제공하는 부문
아다젠 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
LSH
영문 목차
영문목차
Adagen is a brand name for pegademase bovine, an enzyme replacement therapy used to treat severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency. It helps support immune function in individuals with SCID, reducing the risk of life-threatening infections by replenishing the missing enzyme necessary for proper immune system development.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main product forms of adagen are pre-filled syringes and vials. The pre-filled option provides a ready-to-use syringe or device, ensuring convenience and precise dosing for patients. Adagen is primarily used for clinical indications such as severe combined immunodeficiency (SCID) and other rare genetic disorders. It is utilized across various settings, including hospitals and healthcare institutions, specialty clinics, home healthcare services, and research institutions.
The adagen market research report is one of a series of new reports from The Business Research Company that provides adagen market statistics, including adagen industry global market size, regional shares, competitors with a adagen market share, detailed adagen market segments, market trends and opportunities, and any further data you may need to thrive in the adagen industry. This adagen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The adagen market size is expected to see strong growth in the next few years. It will grow to $123.6 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to ongoing innovation in drug delivery systems, growing healthcare infrastructure in emerging economies, increasing accessibility of enzyme replacement therapies, supportive reimbursement policies, and rising prevalence of genetic disorders. Major trends in the forecast period include the introduction of biosimilar enzyme replacement therapies, a focus on reducing production costs, increasing digitalization in healthcare supply chains, collaboration between biotech firms and academic institutions, and advances in long-acting formulations.
The increasing adoption of precision medicine is expected to significantly drive the growth of the adagen market. Precision medicine, which tailors medical treatments to individual genetic profiles, is gaining traction due to advancements in genomic technologies, biomarker availability, artificial intelligence integration, and the growing demand for targeted therapies. Adagen is directly aligned with this shift by providing targeted enzyme replacement therapy for patients with severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency. In 2023, the FDA approved 16 new personalized treatments for rare diseases, reflecting the growing adoption of precision medicine, which will continue to propel the adagen market.
The increasing diagnosis of rare diseases is driving the growth of the adagen market. Rare diseases, which affect fewer than 1 in 2,000 people, are being diagnosed more frequently due to advancements in genetic testing, greater awareness, and better healthcare infrastructure. Adagen contributes to the treatment of SCID, a rare genetic disorder, by offering enzyme replacement therapy, thus supporting early diagnosis and broader research into rare diseases. In the UK alone, over 3.5 million people are affected by rare diseases, which highlights the need for treatments like Adagen to address these conditions, further boosting market demand.
Rising healthcare expenditure is key factor contributing to the growth of the adagen market. As healthcare spending increases due to factors such as medical advancements, aging populations, and rising chronic diseases, the demand for specialized treatments like enzyme replacement therapies is also rising. Adagen's role in treating rare genetic disorders contributes to this rising healthcare expenditure, particularly as the U.S. pharmaceutical industry reached $550 billion in revenue in 2021, with projected spending expected to increase significantly in the coming years. Thus, rising healthcare expenditure supports the continued growth of the Adagen market.
Key player operating in the adagen market are Leadiant Biosciences Inc.
North America was the largest region in the adagen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adagen report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the adagen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The adagen market consists of sales of single-use vials and ready-to-use syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Adagen Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on adagen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for adagen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adagen market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Pre-filled; Vial
2) By Clinical Indication: Severe Combined Immunodeficiency (SCID); Other Rare Genetic Disorders
3) By End User: Hospitals And Healthcare Institutions; Specialty Clinics; Home Healthcare Services; Research Institutions
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Adagen Market Characteristics
3. Adagen Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Adagen Market Trends And Strategies
5. Adagen Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Adagen Growth Analysis And Strategic Analysis Framework
6.1. Global Adagen PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Adagen Market Growth Rate Analysis
6.4. Global Adagen Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Adagen Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Adagen Total Addressable Market (TAM)
7. Global Adagen Market Pricing Analysis & Forecasts
8. Adagen Market Segmentation
8.1. Global Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-filled
Vial
8.2. Global Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Severe Combined Immunodeficiency (SCID)
Other Rare Genetic Disorders
8.3. Global Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Healthcare Institutions
Specialty Clinics
Home Healthcare Services
Research Institutions
9. Global Adagen Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Adagen Market Regional And Country Analysis
10.1. Global Adagen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Adagen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Adagen Market
11.1. Asia-Pacific Adagen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Adagen Market
12.1. China Adagen Market Overview
12.2. China Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Adagen Market
13.1. India Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Adagen Market
14.1. Japan Adagen Market Overview
14.2. Japan Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Adagen Market
15.1. Australia Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Adagen Market
16.1. South Korea Adagen Market Overview
16.2. South Korea Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Adagen Market
17.1. Western Europe Adagen Market Overview
17.2. Western Europe Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Adagen Market
18.1. UK Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Adagen Market
19.1. Germany Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Adagen Market
20.1. France Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Adagen Market
21.1. Eastern Europe Adagen Market Overview
21.2. Eastern Europe Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Adagen Market
22.1. North America Adagen Market Overview
22.2. North America Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Adagen Market
23.1. USA Adagen Market Overview
23.2. USA Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Adagen Market
24.1. Canada Adagen Market Overview
24.2. Canada Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Adagen Market
25.1. South America Adagen Market Overview
25.2. South America Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Adagen Market
26.1. Middle East Adagen Market Overview
26.2. Middle East Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Adagen Market
27.1. Africa Adagen Market Overview
27.2. Africa Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Adagen Market Competitive Landscape And Company Profiles
28.1. Adagen Market Competitive Landscape
28.2. Adagen Market Company Profiles
28.2.1. Leadiant Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Adagen Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Adagen Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Adagen Market
32. Recent Developments In The Adagen Market
33. Adagen Market High Potential Countries, Segments and Strategies
33.1 Adagen Market In 2029 - Countries Offering Most New Opportunities
33.2 Adagen Market In 2029 - Segments Offering Most New Opportunities
33.3 Adagen Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. The Business Research Company
34.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
